Harmony Biosciences Hldgs (HRMY) Stock Price, Quote, News & History

Q: What sector and industry does Harmony Biosciences Hldgs (HRMY) operate in?

Harmony Biosciences Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Harmony Biosciences Hldgs (HRMY) Stock Price, Quote, News & History

HRMYNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$36.52

-0.34-0.92%

At close: Jan 30, 4:00 PM EST

$36.52

N/A

After Hours: 4:00 PM EST

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$36.90

Close

$36.52

Volume / Avg.

444.84K / 754.13K

Day Range

$36.17 - $37.22

52 Wk Range

25.52 - 40.87

Market Cap

$2.10B

P/E Ratio

11.63

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

16.52%

Days to Cover

7.92

Recent Harmony Biosciences Holdings Inc News

Top 3 Health Care Stocks That Are Preparing To Pump In Q4

Avi Kapoor

Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday

Avi Kapoor

Harmony Biosciences' Genetic Disorder Drug Disappoints In Phase 3 Study

Harmony Biosciences' ZYN002 failed to meet its primary goal in a Fragile X Phase 3 trial, but the company points to pipeline growth.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

297.61M

Investing Cash Flow (TTM)

-29.20M

Financing Cash Flow (TTM)

-8.78M

Free Cash Flow (TTM)

296.89M

Capital Expenditure (TTM)

-716.00K

Net Change in Cash (TTM)

259.63M

Analyst Trends and Forecast

4

Sep 25

1

Oct 25

3

Nov 25

1

Dec 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.60B

PE Ratio (TTM)

11.63

PE Ratio (FWD)

8.28

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.62

PB Ratio (TTM)

2.54

Earnings Yield % (TTM)

8.60%

Earnings Yield % (FWD)

12.08%

EV / EBITDA (TTM)

6.00

Price / EBITDA (TTM)

8.01

Price / Free Cash Flow (TTM)

7.28

Book Value / Share

$14.50

Company Debt

Total Debt

$168.51M

LT Debt

$148.51M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$15.00M

Total Cash

$647.00M

Debt to Equity

0.20

Issuance of Debt (TTM)

-$15.00M

Repayment of Debt (TTM)

-$15.00M

Key Statistics

Open

$36.90

Close

$36.52

Volume / Avg.

444.84K / 754.13K

Day Range

$36.17 - $37.22

52 Wk Range

25.52 - 40.87

Market Cap

$2.10B

P/E Ratio

11.63

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

16.52%

Days to Cover

7.92

About

Sector

Health Care

Industry

Pharmaceuticals

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisan...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Harmony Biosciences Hldgs (HRMY) stock?

A

You can purchase shares of Harmony Biosciences Hldgs (NASDAQ:HRMY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Harmony Biosciences Hldgs (HRMY) competitors?

A

Other companies in Harmony Biosciences Hldgs’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), WAVE Life Sciences Ltd (NASDAQ:WVE), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Phibro Animal Health Corp (NASDAQ:PAHC) and Terns Pharmaceuticals Inc (NASDAQ:TERN).

Q

What is the forecast, or price target, for Harmony Biosciences Hldgs (HRMY) stock?

A

Harmony Biosciences Hldgs has a consensus price target of $47.75.

Q

What is the current price for Harmony Biosciences Hldgs (HRMY)?

A

The stock price for Harmony Biosciences Hldgs (NASDAQ: HRMY) is $36.52 last updated January 30, 2026 at 4:00 PM EST.

Q

Does Harmony Biosciences Hldgs (HRMY) pay a dividend?

A

There are no upcoming dividends for Harmony Biosciences Hldgs.

Q

When is Harmony Biosciences Hldgs (NASDAQ:HRMY) reporting earnings?

A

Harmony Biosciences Hldgs does not have any upcoming earnings scheduled.

Q

Is Harmony Biosciences Hldgs (HRMY) going to split?

A

There is no upcoming split for Harmony Biosciences Hldgs.

Q

What sector and industry does Harmony Biosciences Hldgs (HRMY) operate in?

A

Harmony Biosciences Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Supernus Pharmaceuticals Inc

NASDAQ:SUPN

$48.16

%

WAVE Life Sciences Ltd

NASDAQ:WVE

$13.02

0.62%

Tarsus Pharmaceuticals Inc

NASDAQ:TARS

$64.54

%

Phibro Animal Health Corp

NASDAQ:PAHC

$40.15

%

Terns Pharmaceuticals Inc

NASDAQ:TERN

$35.49

2.57%

ANI Pharmaceuticals Inc

Ocular Therapeutix Inc

NASDAQ:OCUL

$9.24

1.09%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$36.90

Close

$36.52

Volume / Avg.

444.84K / 754.13K

Day Range

$36.17 - $37.22

52 Wk Range

25.52 - 40.87

Market Cap

$2.10B

P/E Ratio

11.63

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

16.52%

Days to Cover

7.92

Recent Harmony Biosciences Holdings Inc News

Top 3 Health Care Stocks That Are Preparing To Pump In Q4

Avi Kapoor

Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday

Avi Kapoor

Harmony Biosciences' Genetic Disorder Drug Disappoints In Phase 3 Study

Harmony Biosciences' ZYN002 failed to meet its primary goal in a Fragile X Phase 3 trial, but the company points to pipeline growth.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

297.61M

Investing Cash Flow (TTM)

-29.20M

Financing Cash Flow (TTM)

-8.78M

Free Cash Flow (TTM)

296.89M

Capital Expenditure (TTM)

-716.00K

Net Change in Cash (TTM)

259.63M

Analyst Trends and Forecast

4

Sep 25

1

Oct 25

3

Nov 25

1

Dec 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.60B

PE Ratio (TTM)

11.63

PE Ratio (FWD)

8.28

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.62

PB Ratio (TTM)

2.54

Earnings Yield % (TTM)

8.60%

Earnings Yield % (FWD)

12.08%

EV / EBITDA (TTM)

6.00

Price / EBITDA (TTM)

8.01

Price / Free Cash Flow (TTM)

7.28

Book Value / Share

$14.50

Company Debt

Total Debt

$168.51M

LT Debt

$148.51M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$15.00M

Total Cash

$647.00M

Debt to Equity

0.20

Issuance of Debt (TTM)

-$15.00M

Repayment of Debt (TTM)

-$15.00M

Key Statistics

Open

$36.90

Close

$36.52

Volume / Avg.

444.84K / 754.13K

Day Range

$36.17 - $37.22

52 Wk Range

25.52 - 40.87

Market Cap

$2.10B

P/E Ratio

11.63

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

16.52%

Days to Cover

7.92

About

Sector

Health Care

Industry

Pharmaceuticals

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisan...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry